PCI Pharma Services

PCI Pharma Services is an integrated full-service provider for the global healthcare and pharmaceutical industries. Founded in 2012, the company specializes in analytical services, formulation development, clinical trial supply, and commercial manufacturing. Their technical capabilities extend to complex packaging, QP services, and supply chain management, ensuring end-to-end support for biopharmaceutical clients. By maintaining a robust network across the United States and Europe, they deliver scalable solutions for drug development and commercialization.

Operating with a workforce of 5,000-10,000 employees, PCI Pharma Services manages 18 global locations to support diverse pharmaceutical requirements. Their operational footprint includes advanced laboratory services and in-house analytical facilities designed to meet stringent industry standards. Meet PCI Pharma Services's team to understand their leadership structure and technical expertise in managing complex supply chains. The company leverages industry-leading protocols to ensure safety and quality in every stage of the drug development lifecycle, from initial clinical trials to final commercial distribution.

With an annual revenue of $2.7B, PCI Pharma Services maintains a strong competitive position against industry peers like Catalent and Medpace. The firm secured $920.0M in debt funding in 2020, reflecting significant investor confidence in their growth trajectory. Explore financial highlights to review detailed metrics regarding their market performance and capital structure. As a key player in the pharmaceutical outsourcing sector, the company continues to expand its service offerings, including anti-counterfeiting measures and specialized dosage form development, to address the evolving needs of the global healthcare market.